Further analysis of inflammatory markers revealed that SAP treatment notably decreased systemic and local inflammatory cytokine levels of TNF-α, IL-1β, IL-6, IL-12, and MCP-1, which were closely associated with the severity of lupus nephritis [18]. This evidence concerns the gene IL1B and lupus nephritis.